The European Commission has granted marketing authorisation for Novo Nordisk’s adult diabetes treatments Tresiba and Ryzodeg. The approval covers all 27 European Union member states. Tresiba ...

Rybelsus reduced the risk of cardiovascular-related death, heart attack, and stroke by 14% compared to a placebo over an ...

Novo Nordisk says an oral drug which can help type 2 diabetes patients to lower their blood sugar, substantially lower their risk of having a heart attack or stroke, and help them lose weight ...

diabetes, and other serious chronic illnesses. Indeed, CEO Lars Fruergaard Jorgensen said that Brazil plays a key role in Novo Nordisk’s global plans and that the company exports to over 70 ...

HYDERABAD, April 7 (Reuters) - Danish drugmaker Novo Nordisk (NOVOb.CO), opens new ... plan follows U.S. rival Eli Lilly's launch of its diabetes and obesity drug Mounjaro in India last month.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a ...

Healthcare & Pharmaceuticalscategory· April 7, 2025 Novo Nordisk to invest $1.09 billion to boost Ozempic, Wegovy production in Brazil Novo Nordisk , the producer of Ozempic, Wegovy and other ...

Source: FactSet Markets Diary: Data on U.S. Overview page represent trading in all U.S. markets and updates until 8 p.m. See Closing Diaries table for 4 p.m. closing data. Sources: FactSet ...

Antibiotic Exposure in Infancy May Boost Type 1 Diabetes Risk Mar. 25, 2025 — Exposure to antibiotics during a key developmental window in infancy can stunt growth of insulin-producing cells in ...